These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8972223)

  • 1. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis.
    O'Connor R; Kauffmann-Zeh A; Liu Y; Lehar S; Evan GI; Baserga R; Blättler WA
    Mol Cell Biol; 1997 Jan; 17(1):427-35. PubMed ID: 8972223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
    Dews M; Nishimoto I; Baserga R
    Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.
    Kulik G; Klippel A; Weber MJ
    Mol Cell Biol; 1997 Mar; 17(3):1595-606. PubMed ID: 9032287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
    Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
    Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors.
    Chen H; Yan GC; Gishizky ML
    Cell Growth Differ; 1998 Nov; 9(11):939-47. PubMed ID: 9831246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Shc, Ras, and MAPK activation but normal Akt activation in FL5.12 cells expressing an insulin-like growth factor I receptor mutated at tyrosines 1250 and 1251.
    Leahy M; Lyons A; Krause D; O'Connor R
    J Biol Chem; 2004 Apr; 279(18):18306-13. PubMed ID: 14963047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol.
    Krause D; Lyons A; Fennelly C; O'Connor R
    J Biol Chem; 2001 Jun; 276(22):19244-52. PubMed ID: 11278392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
    Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor.
    Li S; Resnicoff M; Baserga R
    J Biol Chem; 1996 May; 271(21):12254-60. PubMed ID: 8647823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.
    Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R
    Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells.
    Morrione A; Romano G; Navarro M; Reiss K; Valentinis B; Dews M; Eves E; Rosner MR; Baserga R
    Cancer Res; 2000 Apr; 60(8):2263-72. PubMed ID: 10786694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression.
    Soon L; Flechner L; Gutkind JS; Wang LH; Baserga R; Pierce JH; Li W
    Mol Cell Biol; 1999 May; 19(5):3816-28. PubMed ID: 10207105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
    Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
    Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tyrosine residue at 1250 of the insulin-like growth factor I receptor is required for ligand-mediated internalization.
    Miura M; Baserga R
    Biochem Biophys Res Commun; 1997 Oct; 239(1):182-5. PubMed ID: 9345292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grb10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I-, and insulin-mediated mitogenesis.
    Wang J; Dai H; Yousaf N; Moussaif M; Deng Y; Boufelliga A; Swamy OR; Leone ME; Riedel H
    Mol Cell Biol; 1999 Sep; 19(9):6217-28. PubMed ID: 10454568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity.
    Rubin R; Baserga R
    Lab Invest; 1995 Sep; 73(3):311-31. PubMed ID: 7564264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells.
    Miura M; Li S; Baserga R
    Cancer Res; 1995 Feb; 55(3):663-7. PubMed ID: 7834637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis.
    Cortez D; Kadlec L; Pendergast AM
    Mol Cell Biol; 1995 Oct; 15(10):5531-41. PubMed ID: 7565705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1).
    Galvan V; Logvinova A; Sperandio S; Ichijo H; Bredesen DE
    J Biol Chem; 2003 Apr; 278(15):13325-32. PubMed ID: 12556535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.